Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA® (estradiol transdermal system) Initial U.S. Approval: 1975
Medication labelWhy this: Advisory · dailymed-prescription
LYLLANA is indicated for: Limitation of Use When prescribing solely for the prevention of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis.
- generic_name
- estradiol
- product_names
- Estradiol
- ndc
- 65162-126, 65162-148, 65162-149, 65162-150, 65162-228, 65162-126-04, 65162-126-08, 65162-148-04, 65162-148-08, 65162-149-04, 65162-149-08, 65162-150-04, 65162-150-08, 65162-228-04, 65162-228-08
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en